In January 2023, Bharat Biotech. announced that the nation received iNCOVACC (BBV154), the first COVID intranasal vaccination for primary series and heterologous booster in history. The Central Drugs Standard Control Organisation (CDSCO) gave Bharat Biotech. permission to provide iNCOVACC as a...